Hernia Mesh Lawsuits in 2026: Complications, Bellwether Trials and Who Qualifies
Hernia mesh lawsuits allege that polypropylene surgical mesh products caused chronic pain, organ damage, and repeat surgeries, with thousands of cases consolidated in federal multidistrict litigations. This guide covers the complications behind the claims, the bellwether trial results that shaped the litigation, and who qualifies to file.
For a visual walkthrough of money and debt topics, you can also follow the Problem Solved channel.
Key facts
- Federal cases against C.R. Bard are consolidated as MDL 2846, In re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation, in the Southern District of Ohio.
- Bard bellwether verdicts include a $255,000 plaintiff verdict (Johns, 2021), a defense verdict (Stinson, 2022), and a $500,000 plaintiff verdict (Miller, 2022).
- Ethicon withdrew its Physiomesh product from the global market in 2016 after registry data showed higher revision rates.
- Atrium C-QUR mesh cases are consolidated separately as MDL 2753 in the District of New Hampshire.
- The manufacturers named across the litigations include C.R. Bard, Ethicon (Johnson and Johnson), Atrium, and Covidien/Medtronic.
What hernia mesh is and why it fails
Hernia mesh, defined once here, is a synthetic screen, usually woven polypropylene, implanted to reinforce weakened abdominal tissue during hernia repair. It is one of the most commonly implanted medical devices in the world, used in the large majority of hernia repairs. The lawsuits allege that specific mesh designs were defective: that the polypropylene degrades and oxidizes in the body, that the mesh shrinks, hardens, and migrates from its original position, and that coatings meant to prevent adhesions instead caused their own problems. Plaintiffs do not claim all mesh is defective; they claim particular products carried unreasonable risks the manufacturers failed to warn about. That product-specific focus is why attorneys always ask exactly which mesh was implanted and when.
The complications behind the claims
The injuries alleged across the MDLs form a consistent pattern. Chronic pain is the most common complaint: nerve entrapment and mesh contraction can cause debilitating pain years after surgery. Mesh migration and shrinkage can pull the device from the repair site, causing hernia recurrence. Organ perforation and bowel obstruction occur when migrating mesh erodes into adjacent organs. Infection can force complete mesh removal. Revision surgery to remove or replace failed mesh is both a qualifying injury and the event that generates the medical records proving the claim. Plaintiffs allege the manufacturers knew of these failure modes from internal testing and adverse event reports.
Bellwether trials: what the verdicts taught
MDL 2846 moved through a bellwether process of early test trials showing both sides how juries receive the evidence. The results were split. Johns v. Bard (2021) brought a $255,000 plaintiff verdict; Stinson v. Bard (2022) a defense verdict; Miller v. Bard (2022) a $500,000 plaintiff verdict. Split bellwethers are the classic setup for settlement: neither side can count on winning every trial, so both sides have reason to deal. Plaintiffs win when they show a specific design defect connected to the injury through credible experts; they lose when the defense convinces jurors the complication was a known surgical risk. Every case filed since has been shaped by those lessons.
Who qualifies to file
Most filed cases involve implants from the 2000s and 2010s. You will need to identify the mesh manufacturer and product from your operative report; attorneys obtain this record first. Cases are generally filed on contingency, so there is no upfront cost. Not every bad surgical outcome is a product case: infections and pain can result from surgical technique, and honest firms screen for product-specific evidence before filing.
The Ethicon and Atrium litigations
Bard is the largest but not the only front. Ethicon, the Johnson and Johnson subsidiary, faces claims over its Physiomesh and other hernia mesh products; the company's 2016 global withdrawal of Physiomesh, after registry data showed higher rates of revision surgery, is a centerpiece of plaintiffs' cases. Atrium Medical's C-QUR mesh is the subject of MDL 2753 in New Hampshire, with plaintiffs alleging its coating caused severe inflammatory responses. Covidien, now part of Medtronic, faces claims over its Parietex and other mesh lines. Each litigation has its own science and settlement posture, which is why the product name on your operative report determines which litigation your case joins.
How these cases resolve and what affects value
Compensation varies widely by case, and most settlements in mass torts are confidential. Value tracks injury severity and permanence: revision surgery with lasting impairment commands more than a resolved infection. Bellwether verdicts anchor negotiations. Economic losses add to noneconomic damages for pain and suffering. Cases take years from filing to any payment, and joining the litigation early costs nothing while preserving your place. Get the contingency fee agreement in writing before you sign.
Who Benefits From This — and Who Does Not
Who benefits from this guide?
- People with hernia mesh implanted in the 2000s or 2010s. Most filed cases involve implants from those decades — if your operative report names a mesh product, this guide shows which litigation it points to.
- Patients with chronic pain, mesh migration, or a repeat repair. Revision surgery to remove or replace failed mesh is both a qualifying injury and the event that generates the medical records proving the claim, and chronic pain is the most common complaint alleged.
- Anyone whose mesh came from Bard, Ethicon, Atrium, or Covidien/Medtronic. These are the manufacturers named across the litigations — and the product name on your operative report determines whether your case joins MDL 2846, MDL 2753, or another front.
- Readers following the bellwether verdicts. The split Bard results — a $255,000 plaintiff verdict in Johns (2021), a defense verdict in Stinson (2022), and a $500,000 plaintiff verdict in Miller (2022) — anchor settlement negotiations, so understanding them helps you read what happens next.
Who does NOT benefit — or needs something else?
- People whose complications came from surgical technique, not the product. Not every bad surgical outcome is a product case — infections and pain can result from surgical technique, and honest firms screen for product-specific evidence before filing.
- Patients with pain alone and no objective findings. Pain alone is harder to prove than pain plus objective findings like migration or recurrence — medical documentation of the pain and its impact is essential.
- Anyone expecting quick payment. Cases take years from filing to any payment, and most settlements in mass torts are confidential — joining early costs nothing but does not pay quickly.
General information only — not legal or medical advice. Whether a hernia mesh case qualifies turns on the specific product implanted and the medical records; consult a qualified attorney about your situation.
Related guide: ParaGard IUD Lawsuits in 2026: the Claims, Settlement Status, and Who Qualifies
Frequently asked questions
What is MDL 2846?
MDL 2846 is the federal multidistrict litigation, In re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation, in the Southern District of Ohio, consolidating federal lawsuits over Bard hernia mesh products for pretrial proceedings, including the bellwether trial program.
How do I find out which mesh was implanted?
Your operative report from the hernia repair names the manufacturer and product. Your surgeon's office or the hospital medical records department can provide it. Attorneys request this record first, because the product name determines which litigation your case belongs in.
Do I qualify if my only problem is pain?
Chronic pain well beyond normal recovery is a commonly alleged injury, but pain alone is harder to prove than pain plus objective findings like migration or recurrence. Medical documentation of the pain, its treatment, and its impact on your life is essential.
What did the bellwether trials decide?
Three Bard bellwethers went to verdict: $255,000 for the plaintiff in Johns (2021), a defense verdict in Stinson (2022), and $500,000 for the plaintiff in Miller (2022). Bellwether verdicts do not bind other plaintiffs, but they set the settlement negotiating range.
How much does it cost to file?
Mass tort firms work on contingency: no upfront fee, with the firm taking an agreed percentage of any recovery plus costs. Get the fee agreement in writing before you sign anything.
Who benefits most from this guide?
People who had hernia mesh implanted in the 2000s or 2010s and now live with chronic pain, mesh migration, organ injury, or a repeat repair. Most filed cases involve implants from those decades, and the product name on your operative report decides which litigation your case joins — MDL 2846 for Bard, MDL 2753 for Atrium C-QUR — so this guide's first gate is knowing exactly which mesh was implanted.
Who does NOT qualify for a hernia mesh claim?
Not every bad surgical outcome is a product case: infections and pain can result from surgical technique, and honest firms screen for product-specific evidence before filing. People with normal recovery symptoms, complications tied to the surgery itself rather than the mesh product, and pain without objective findings like migration or recurrence are unlikely to qualify.
What are my first steps if I think I qualify?
Get your operative report from the surgeon's office or the hospital medical records department — attorneys request it first because the mesh manufacturer and product name determine which litigation your case belongs in. Cases are generally filed on contingency, so there is no upfront cost; get the contingency fee agreement in writing before you sign.
For a parallel device-liability litigation, see the DePuy Attune knee implant guide and the pharmacy opioid settlements breakdown.
This article is general information, not legal, financial or medical advice. Consult a qualified professional about your specific situation.